Success Metrics

Clinical Success Rate
100.0%

Based on 3 completed trials

Completion Rate
100%(3/3)
Active Trials
2(40%)
Results Posted
33%(1 trials)

Phase Distribution

Ph phase_3
1
20%
Ph phase_2
1
20%
Ph not_applicable
2
40%

Phase Distribution

0

Early Stage

1

Mid Stage

1

Late Stage

Phase Distribution4 total trials
Phase 2Efficacy & side effects
1(25.0%)
Phase 3Large-scale testing
1(25.0%)
N/ANon-phased studies
2(50.0%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

100.0%

3 of 3 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

2

trials recruiting

Total Trials

5

all time

Status Distribution
Active(2)
Completed(3)

Detailed Status

Completed3
Recruiting2

Development Timeline

Analytics

Development Status

Total Trials
5
Active
2
Success Rate
100.0%
Most Advanced
Phase 3

Trials by Phase

Phase 21 (25.0%)
Phase 31 (25.0%)
N/A2 (50.0%)

Trials by Status

recruiting240%
completed360%

Recent Activity

2 active trials
Showing 5 of 5
recruiting

Selective Sentinella Lymph Node Biopsy with Indocyanine Green in Patients with Breast Cancer

NCT06378944
recruitingphase_2

Sentinel Lymph Node Localisation With an Ultra-low Dose of Magtrace in Breast Cancer Patients

NCT06169072
completedphase_3

Fluorescence for Sentinel Lymph Node Identification in Cancer Surgery

NCT02997553
completednot_applicable

Infrared Lymphangiography as a Method of Sentinel Node Identification

NCT02057393
completednot_applicable

Sentinel Lymph Node Mapping in Detecting Cancer That Has Spread to Lymph Nodes in Patients With Non-Small Cell Lung Cancer

NCT00089310

Clinical Trials (5)

Showing 5 of 5 trials
NCT06378944

Selective Sentinella Lymph Node Biopsy with Indocyanine Green in Patients with Breast Cancer

Recruiting
NCT06169072Phase 2

Sentinel Lymph Node Localisation With an Ultra-low Dose of Magtrace in Breast Cancer Patients

Recruiting
NCT02997553Phase 3

Fluorescence for Sentinel Lymph Node Identification in Cancer Surgery

Completed
NCT02057393Not Applicable

Infrared Lymphangiography as a Method of Sentinel Node Identification

Completed
NCT00089310Not Applicable

Sentinel Lymph Node Mapping in Detecting Cancer That Has Spread to Lymph Nodes in Patients With Non-Small Cell Lung Cancer

Completed

All 5 trials loaded

Drug Details

Intervention Type
DEVICE
Total Trials
5